GP Healthcare Capital logo

GP Healthcare Capital

Asia, Shanghai, China, Shanghai

Description

GP Healthcare Capital is a venture capital that makes investments in companies based in the biotechnology industry.

Investor Profile

GP Healthcare Capital has made 4 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Series B (50%)
  • Series Unknown (25%)
  • Series A (25%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Oncology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does GP Healthcare Capital frequently co-invest with?

CICC
Asia, Beijing, China, Beijing
Co-Investments: 1
GL Ventures LLC
Asia, Beijing, China, Beijing
Co-Investments: 1
China Asset Management
Asia, Beijing, China, Beijing
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
PICC Capital Investment Management
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CL
Asia, Beijing, China, Beijing
Co-Investments: 1
Forebright Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
FutureX Capital
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
CD Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
ABC International
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1

What are some of recent deals done by GP Healthcare Capital?

Jenscare Biotech

Ningbo, Zhejiang, China

Ningbo Jenscare Scientific is a medical device company.

BiotechnologyHealth Care
Series UnknownMay 28, 2021
Laekna Therapeutics

Shanghai, Shanghai, China

Laekna Therapeutics is a biotech company focusing on drug discovery and development.

Biotechnology
Series BApr 2, 2019
Amount Raised: $27,500,000
GenomiCare Biotechnology

Shanghai, Shanghai, China

GenomiCare Biotechnology is a Chinese precision cancer medicine service company

BiotechnologyHealth Care
Series ADec 18, 2018
Amount Raised: $30,000,000
Adagene

Suzhou, Jiangsu, China

Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies.

BiotechnologyMedicalOncologyTherapeutics
Series BJan 29, 2016
Amount Raised: $28,000,000